Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Price:
19.7 CNY
0.56%
Market Closed
Updated:
May 22, 2024
P/E
Price to Earnings
Price to Earnings
144.5
Current
2.9
Median
24.1
Industry
Higher
than median
Higher
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=144.5
Market Cap
/
4.6B
Net Income
31.5m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CN |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
|
4.6B CNY | 144.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182.1B USD | 32.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
142.9B USD | 71.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.4B USD | 37.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.8B USD | 27.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
111.1B USD | 62.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.4B USD | 51.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
60.4B EUR | 32.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
54.7B USD | 38.7 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.7B USD | 80.9 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.9B CNY | 30.3 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
hidden
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A
You don't have any saved screeners yet
